Variant report

Variant	rs552083268
Chromosome Location	chr13:110395771-110395772
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr13:110394415..110400324-chr13:110434969..110439511,6	K562	blood:
2	chr13:110391823..110394332-chr13:110394549..110396168,2	K562	blood:
3	chr13:110394415..110400589-chr13:110436285..110439325,5	K562	blood:

Variant related genes	Relation type
ENSG00000185950	Chromatin interaction

Extended variants
information (count: 5 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1044855	chr13:110301572-110408608	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
2	nsv826788	chr13:110381750-110469062	Flanking Bivalent TSS/Enh Genic enhancers Enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
3	nsv826789	chr13:110387268-110473524	Weak transcription Genic enhancers Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
4	nsv526943	chr13:110393477-110421884	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
5	nsv826790	chr13:110395165-110463032	Weak transcription Genic enhancers Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:41 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:110386000-110396200	Weak transcription	Gastric	stomach
2	chr13:110390200-110396600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr13:110390200-110396800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr13:110390400-110396200	Weak transcription	Brain Hippocampus Middle	brain
5	chr13:110390400-110396400	Weak transcription	Placenta Amnion	Placenta Amnion
6	chr13:110390600-110396000	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr13:110390600-110396400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr13:110390800-110402200	Weak transcription	HSMM	muscle
9	chr13:110391000-110395800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr13:110391000-110396000	Weak transcription	Fetal Heart	heart
11	chr13:110391000-110396400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr13:110391200-110402600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
13	chr13:110391200-110404400	Weak transcription	HSMMtube	muscle
14	chr13:110392200-110396200	Weak transcription	Fetal Brain Male	brain
15	chr13:110392800-110396200	Weak transcription	Primary monocytes fromperipheralblood	blood
16	chr13:110392800-110396200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr13:110393200-110395800	Weak transcription	HUVEC	blood vessel
18	chr13:110393200-110396600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
19	chr13:110393800-110396400	Weak transcription	Spleen	Spleen
20	chr13:110394400-110396800	Weak transcription	Lung	lung
21	chr13:110395200-110397200	Enhancers	Duodenum Mucosa	Duodenum
22	chr13:110395200-110397400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr13:110395400-110396000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr13:110395400-110396200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr13:110395400-110396600	Enhancers	NHEK	skin
26	chr13:110395400-110397000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
27	chr13:110395400-110397400	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr13:110395400-110397400	Enhancers	HMEC	breast
29	chr13:110395600-110395800	Enhancers	Primary hematopoietic stem cells	blood
30	chr13:110395600-110395800	Enhancers	Colonic Mucosa	Colon
31	chr13:110395600-110395800	Enhancers	Pancreatic Islets	Pancreatic Islet
32	chr13:110395600-110396000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr13:110395600-110396200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr13:110395600-110396200	Enhancers	A549	lung
35	chr13:110395600-110396200	Enhancers	Dnd41	blood
36	chr13:110395600-110396200	Enhancers	Hela-S3	cervix
37	chr13:110395600-110396800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
38	chr13:110395600-110397600	Enhancers	Fetal Lung	lung
39	chr13:110395600-110397600	Enhancers	Placenta	Placenta
40	chr13:110395600-110397600	Enhancers	Sigmoid Colon	Sigmoid Colon
41	chr13:110395600-110404000	Weak transcription	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links